H.B. Fuller FUL illustration showing eight directors buying $1.12M in shares, specialty adhesives production and 21% adjusted EPS growth.

H.B. Fuller ($FUL): 8 Directors Buy $1.12M in Stock—What Do They Know? 🧪💰

Eight H.B. Fuller ($FUL) directors have purchased approximately $1.12 million in stock near $50, following an earlier $295,000 purchase by CEO Celeste Mastin. Meanwhile, adjusted EPS jumped 21%, EBITDA margins reached a record 19.9%, and the stock trades at a forward P/E near 10×. Is this overlooked specialty adhesives manufacturer a compelling value opportunity—or a value trap? Our FunStock Index™: 8.0/10. 🧪📈

Read entire article

Howard Hughes HHH illustration showing real estate and Vantage reinsurance platforms, Bill Ackman's $2.1B deal and $1.67M insider buying.

Howard Hughes ($HHH): Bill Ackman's $2.1B Insurance Bet—The Next Berkshire? 🏢🚀

Bill Ackman is reshaping Howard Hughes Holdings ($HHH). The $2.1 billion acquisition of Vantage creates a new specialty insurance and reinsurance platform alongside valuable master-planned communities. Add $1.67 million in fresh executive buying, Pershing Square's approximately 46.6% stake and a potentially interesting valuation, and the investment thesis becomes fascinating. Is HHH evolving into a Berkshire-style compounder—or simply becoming more complicated? Our FunStock Index™: 8.2/10. 🏢⚡

Read entire article

Hormel Foods HRL turnaround illustration featuring a Dividend King crown, SPAM and Skippy products, a 6% yield and the $1.055B Brakebush deal.

Hormel Foods ($HRL): A 6% Dividend King, a $1 Billion Chicken Bet—and a Turnaround Brewing 🥩👑

Hormel Foods ($HRL) isn't just SPAM, Skippy and Planters anymore. At $19.55, this 60-year Dividend King offers a nearly 6% yield, a $201,000 chairman insider purchase, incoming CEO John Ghingo and a $1.055 billion acquisition of Brakebush Brothers. Add improving adjusted profitability, meaningful cash flow and a skeptical Wall Street, and the ingredients for a turnaround start looking interesting. Our FunStock Methodology™ puts the signals to the test. 🥩👑

Read entire article

A premium editorial illustration of the iconic Energizer Bunny confidently marching through a quiet suburban neighborhood at sunrise while carrying a glowing battery. Behind the bunny are subtle symbols of recurring consumer demand

🔋 Energizer (ENR): The Battery Maker Wall Street Forgot

Wall Street loves exciting stories. Energizer sells batteries. Yet behind the famous pink bunny lies a surprisingly compelling value story featuring relentless insider buying, robust free cash flow, a nearly 6% dividend yield, and a stock trading at roughly 5.5x forward earnings.

Read entire article

A living room featuring a modular Lovesac-style sectional transforming like building blocks into multiple configurations. Each section glows with labels such as

🛋️ Lovesac (NASDAQ: LOVE) Stock Analysis: Is This Premium Furniture Innovator Deeply Undervalued?

Most furniture companies sell sofas.

Lovesac sells a platform.

Its modular Sactionals ecosystem encourages repeat purchases, customer loyalty, and long-term engagement while trading at valuation multiples that appear surprisingly inexpensive.

Read entire article

A confident insurance executive in a tailored suit stands on a bridge connecting a suburban American neighborhood to a modern global financial skyline. One side features homes, mortgages, and family life; the other displays specialty insurance markets.

🏠 Radian Group Inc. (NYSE: RDN): New C-Suite Blood, The $1.7 Billion Global Pivot, and a Comical 6x Valuation

A new CEO. A $5.8 million insider purchase. A $1.7 billion transformational acquisition. And a stock trading below book value at just 6.6x forward earnings. Is Wall Street overlooking one of the most compelling value opportunities in financials?

Read entire article

Digital illustration showing a cheerful scientist beside a beaker, a bullish stock chart, and a small cartoon bull — symbolizing Revvity’s blend of biotech innovation, strong institutional backing, and renewed investor optimism.

Some Funds Are Adding and Analysts Are Rather Bullish: Should You Buy Shares of Revvity (RVTY)?

Revvity (RVTY) may not make flashy headlines, but it’s quietly building a powerful comeback story. With top institutions buying, analysts turning bullish, and profits stabilizing, this former PerkinElmer spinout is morphing into a biotech value gem. Here’s why investors — and scientists — are both smiling (in lab coats).

Read entire article

Cartoon-style digital illustration of a sneaker-shaped stock chart bouncing on a trampoline labeled

Nike: Invest for Value in the Nick of Time?

Nike’s been knocked down, but insiders and institutions aren’t ready to quit. With strong cash flow, consistent dividends, and that iconic swoosh, is it time to just do it—or jog the other way?

Read entire article

Cartoon-style image of a Pepsi bottle standing confidently next to a bag of Lay's chips and a Gatorade bottle, all with smiling faces and dollar signs in their eyes. A rising stock chart in the background suggests financial growth.

🥤 PepsiCo: More Than Just Soda—A Value Investment That Might Just Pop! 🍿

PepsiCo isn’t just about soda anymore—it’s a diversified powerhouse with brands like Lay’s, Gatorade, and Tropicana, delivering steady revenue growth and shareholder returns. With a rock-solid balance sheet, increasing dividends, and strong global presence, PepsiCo might just be the value play your portfolio needs.

Read entire article